CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 241,703 shares at $34.55 ($8,350,839)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 120,164 shares at $33.30 ($4,001,461)
- 4 Open-market sale 10% owner sold 140,000 shares at $33.30 ($4,662,000)
- 4 Open-market sale Director sold 245,000 shares at $28.75 ($7,044,412)
- 4 Open-market sale 10% owner sold 245,000 shares at $28.75 ($7,044,412)
- 4 Open-market sale Director sold 255,000 shares at $35.15 ($8,963,250)
- 4 Open-market sale 10% owner sold 255,000 shares at $35.15 ($8,963,250)
Page 7 of 9 · 180 filings